Literature DB >> 23776300

Providing power for miniaturized medical implants: triplet sensitization of semiconductor surfaces.

Andrew C Benniston1, Anthony Harriman, Songjie Yang.   

Abstract

Here, we recognize the growing significance of miniaturized devices as medical diagnostic tools and highlight the need to provide a convenient means of powering such instruments when implanted into the body. One of the most promising approaches to this end involves using a light-collection facility to absorb incident white light and transfer the photonic energy to a tiny semiconductor embedded on the device. Although fluorescent organic molecules offer strong potential as modules for such solar collectors, we emphasize the promise offered by transition metal complexes. Thus, an extended series of binuclear Ru(II)/Os(II) poly(pyridine) complexes has been shown to be highly promising sensitizers for amorphous silicon solar cells. These materials absorb a high fraction of visible light while the Ru(II)-based units possess triplet energies that are comparable to those of the naphthalene-based bridge. The metal complex injects a triplet exciton into the bridge and this, in turn, is trapped by the Os(II)-based terminal. The result is extremely efficacious triplet-energy transfer; at room temperature the rate of energy transfer is independent of distance over some 6 nm and only weakly dependent on temperature.

Entities:  

Keywords:  energy transfer; metal poly(pyridine) complexes; nanoparticles; photophysics; triplet state

Mesh:

Year:  2013        PMID: 23776300     DOI: 10.1098/rsta.2012.0334

Source DB:  PubMed          Journal:  Philos Trans A Math Phys Eng Sci        ISSN: 1364-503X            Impact factor:   4.226


  1 in total

1.  Spectroscopic Study of Solvent Polarity on the Optical and Photo-Physical Properties of Novel 9,10-bis(coumarinyl)anthracene.

Authors:  Hasnaa M Fahmy; Hamed M Kandel; Hamdan A S Al-Shamiri; Nabel A Negm; Ahmed H M Elwahy; Maram T H Abou Kana
Journal:  J Fluoresc       Date:  2018-10-21       Impact factor: 2.217

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.